Quality Risk Management Overview


OVERVIEW
After attending this course the audience will
  • Recognize the purpose and value of Quality Risk Management (QRM), as well as how it applies to your job.
  • Explain the level of risk based on severity, occurrence, and detectability and how the QRM process is used to make decisions.
  • Identify key QRM terminology.
  • Recognize the four (4) key components of Quality Risk Management
  • Identify examples of Quality Risk Management tools and their application.
WHY SHOULD YOU ATTEND
Per ICH Q10 Quality risk management is integral to an effective pharmaceutical quality system. It can provide a proactive approach to identifying, scientifically evaluating and Controlling potential risks to quality. However integrating the principles of QRM into our quality processes is complex especially in a pharmaceutical organization. There is much confusion on how to define risk and individuals often think of quality risk management as just a tool like FMEA analysis verses an overall QRM approach. This training will explain the important concepts associated with a QRM approach.
AREAS COVERED
  • Recognize the purpose and value of Quality Risk Management (QRM), as well as how it applies to your job.
  • Explain the level of risk based on severity, occurrence, and detectability and how the QRM process is used to make decisions.
  • Identify key QRM terminology.
  • Recognize the four (4) key components of Quality Risk Management
  • Identify examples of QRM tools and their application.
LEARNING OBJECTIVES
Attendees will come away with the ability to recognize the purpose and value of Quality Risk Management QRM, explain the level of risk based on severity, occurrence, and detectability and how the QRM process is used to make decisions. In addition they will be able to identify key QRM terminology and recognize the four (4) key components of Quality Risk Management. Finally they will have a strong understanding of the key concepts associated with the risk management risk tools and their application.
WHO WILL BENEFIT
This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms. This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products. Following personnel will benefit from the course:
  • Senior quality managers
  • Quality professionals
  • Regulatory professionals
  • Compliance professionals
  • Production supervisors
  • Manufacturing engineers
  • Production engineers
  • Process owners
  • Quality engineers
  • Quality auditors
  • Development professionals
  • Senior development managers

For more detail please click on this below link:
http://bit.ly/2NzPg9e


Email: support@trainingdoyens.com
Toll Free: +1-888-300-8494
Tel: +1-720-996-1616
Fax: +1-888-909-1882



Comments

Post a Comment

Popular posts from this blog

Effectively Handle Toxic People for Better Productivity and Less Drama in 2020

Image
We all have people who push our buttons and if that relationship is with our boss, colleagues or clients, it can drain our energy, take us off track and infect the other areas of our life. Our upcoming webinar discusses successful strategies and tips for building a positive, productive relationship by knowing how to effectively respond to, cope, and manage the impact of their negative and toxic behavior in the workplace. The webinar covers the following key areas: ·          Identify and control the impact of difficult people so that you can keep the situation from escalating further ·          Differentiate the 4 types of attitudes and understand how they develop in order to keep your cool in a variety of situations ·          Utilize various verbal and non-verbal communication techniques and situational strategies that you can use to de-escalate and effectively handle upset people LEARNING OBJECTIVES Learn successful strategies and tips for building a positive, productive
Read more

All About Civility - Eliminating a Culture of Gossip, Rumors and Destructive Behavior: Whatever Happened to Respect?

Image
OVERVIEW Whatever happened to respect and civil behavior? What is the cost when we lose both? Uncivil behavior, left unaddressed, begins a downward spiral you and your employees can’t afford. Incivility, leads to gossip in the workplace , rumors, and then to bullying in the workplace, harassment and ultimately, what we see too much in the news every day now, sexual harassment. Overworked, disengaged and undisciplined staff does more harm to your reputation and employee productivity than you can afford. A workplace culture of tolerating a bad attitude by one or more employees is not acceptable. The cause of the employee attitude is generated from how they are treated at work, a seeming lack of respect of them. Is it you or is it the other person that is the real problem? Respect comes from dealing with the situation when it becomes evident. This presentation is about dealing with gossip in the workplace, how to change the behavior, and how to make employees to be solution o
Read more

BCBS 239 – Principles of Effective Risk Data Aggregation and Risk Reporting

Image
OVERVIEW Understanding the process required to ensure compliance withBCBS 239 as well as tips on ensuring that the right data is utilized. Finally, a detailed step by step analysis of COSO requirements and what a business can do to meet expectations. COSO continues to provide guidance and establish standards for performance in risk related processes.  BCBS 239 is the latest in a series of instructions which focuses on risk data aggregation. This webinar will include discussions on the risk data aggregation capabilities and internal risk-reporting practices (the Principles) that enhance risk management and decision making processes at financial institutions. BCBS 239 Compliance WHY SHOULD YOU ATTEND Early in 2015, the Basel Committee published the second progress report on bank’s adoption of BCBS 239. Several banks, at that time, stated that they would not be able to comply with the new standards by the 2016 deadline date.  However, regulators are now looking at how ins
Read more